—
C+
C+ The full Closelook — membership. Open the C+ overview

Quest Diagnostics Incorporated (DGX) — chart, structure and Closelook read

Home› Indices›
Pick a ticker to load its detail page.

Company snapshot — Quest Diagnostics Incorporated

DGX in five paragraphs: what it makes and sells, where it sits in the Closelook stack, who it is priced against, why we track it, what we watch. Research diary, not advice.

What it does
Quest Diagnostics runs clinical laboratories and patient service centres across the United States, processing blood, tissue and other samples for hospitals, doctors and insurers. It offers routine and advanced testing in areas such as cancer, infectious disease, drug monitoring and women's health, plus risk-assessment work for life insurers and IT tools that connect results to health systems. It operates under several brands, including AmeriPath and ExamOne, alongside the main Quest Diagnostics name. It is headquartered in Secaucus, New Jersey.
Where it sits in the stack
Quest sits outside our index; it belongs to the diagnostics and research sleeve of the Healthcare sector rather than any layer of the AI build-out.
Who it is priced against
Our peer group carries no comparison for Quest; the market usually names Labcorp as its closest competitor in large-scale clinical laboratory testing.
Why Closelook tracks it
Quest holds a seat in the S&P 500 but none in our index, and it carries no Closelook score. The one quote that names 'DGX' in the diary refers to Nvidia's DGX Cloud product, not to Quest Diagnostics, so it is a ticker coincidence rather than coverage of the company.
What the diary watches
Whether Quest ever appears in the diary through its own testing volumes rather than through a shared ticker with an unrelated product.

Quest Diagnostics Incorporated (DGX) trades on US exchanges.

Written from the company’s public profile and Closelook’s own readings, 2026-09-17. Descriptive, refreshed with the registry; corrections welcome via the imprint. closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: index compare · sector dispersion · scanner.

Signals for this name

Every Closelook reading that exists for DGX, from the same nightly bakes the boards use. Research diary readings, not advice.

The Street on this name 1 analyst action on the wire · latest: price target by UBS, 2026-09-08

The Street on this name

Analyst actions and the latest print for DGX from the Closelook wires — third-party opinions on the record, not our readings.

  • Price target UBS — target 245 from 232 Target raised to $245 from $232 (+4% to spot) 2026-09-08

1 action on the analyst wire since 2026-08-13: 1 target change. Analyst wire → · Earnings wire →

Weather around the name 3 macro readings: Money Temperature, Factor regime, Sovereign pressure

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

  • Money Temperature Composite 55/100 · S&P 500 fund at 58, above its 50- and 200-day averagesEight instruments scored on position, momentum, volume, volatility and fragility — the regime every name trades inside. Temperature lab → 2026-09-17
  • Factor regime Momentum leading — risk appetite buildingMomentum against low volatility (SPMO / SPLV): above its 50-day trend, 94th percentile of the window, +2.7% over 20 sessions. Factor regime → 2026-09-17
  • Sovereign pressure Index 0.00 · down 0.41 over 21 sessionsG7 long-end yields, 10s30s and the slope — the funding weather for every balance sheet on this site. Sovereign pressure → 2026-09-17

FAQ · from the current data · as of 2026-09-18

Quick answers

What is Quest Diagnostics Incorporated (DGX)?

Quest Diagnostics Incorporated trades as DGX on the US exchange (United States) in the Closelook research universe, as of the registry build of 2026-09-18.

Is DGX in a Closelook index?

Not currently — Quest Diagnostics Incorporated is tracked in the Closelook research universe but is not a constituent of a Closelook functional index as of 2026-09-18.

Where does DGX trade against its moving averages?

Uptrend stack intact: Trades +6.7% vs the 50-day and +22.1% vs the 200-day average, 0.5% below the 52-week high and +45.9% off the 52-week low. Computed from daily closes. As of 2026-09-17 — a technical state from the nightly Closelook bake, not advice. The Technical tab carries the full row.

What does Quest Diagnostics Incorporated do?

Quest Diagnostics runs clinical laboratories and patient service centres across the United States, processing blood, tissue and other samples for hospitals, doctors and insurers. It offers routine and advanced testing in areas such as cancer, infectious disease, drug monitoring and women's health, plus risk-assessment work for life insurers and IT tools that connect results to health systems. It operates under several brands, including AmeriPath and ExamOne, alongside the main Quest Diagnostics name. Our peer group carries no comparison for Quest; the market usually names Labcorp as its closest competitor in large-scale clinical laboratory testing.

Where does Quest Diagnostics Incorporated sit in the AI build-out?

Quest sits outside our index; it belongs to the diagnostics and research sleeve of the Healthcare sector rather than any layer of the AI build-out. Quest holds a seat in the S&P 500 but none in our index, and it carries no Closelook score. The one quote that names 'DGX' in the diary refers to Nvidia's DGX Cloud product, not to Quest Diagnostics, so it is a ticker coincidence rather than coverage of the company.

What has Wall Street done on Quest Diagnostics Incorporated recently?

The most recent analyst action on Quest Diagnostics Incorporated on the Closelook wire is a price target by UBS on 2026-09-08 (target 245 from 232). 1 action on the analyst wire since 2026-08-13: 1 target change. Analyst actions are third-party opinions recorded by the wire, not Closelook readings. The “The Street on this name” block on this page lists the moves; the full feeds are the analyst wire and the earnings wire.

Where has Closelook written about Quest Diagnostics Incorporated?

Quest Diagnostics Incorporated appears in 1 Closelook piece, most recently 101: Sovereign AI: The National Compute Arms Race and Its Investment Map. What Closelook said most recently: The investment implications span from NVIDIA (selling DGX Cloud to governments globally) to Nebius (Yandex spin-off building European sovereign cloud) to Dell and HPE (on-premises AI infrastructure for nations with data residency… (101). The "Mentioned on Closelook" block on this page lists the long reads, the reference entries and the dailies that name it.

What does this page show?

A live price chart with SMA overlays and drawing tools for DGX, performance metrics, index-membership context and the Closelook structure read — an investment research diary view, not investment advice.

Mentioned on Closelook 1 piece · newest: 101, “Sovereign AI: The National Compute Arms Race and Its Investment Map”

Mentioned on Closelook

Where DGX appears in the diary — 1 piece, newest first. Every link is our own writing.

101 and glossary

Related in the Closelook universe